Skip to main content

Table 3 Base case results for CVD risk without and with diabetes for four risk levels. All dominated strategies have been excluded

From: Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study

CVD risk

Strategy

Cost

IC

Eff

IE

ICER

Strategy

Cost

IC

Eff

IE

ICER

Low risk

     

Moderate risk

     

   No treatment

461

 

0.00

  

No treatment

1516

 

0.00

  

   ACEI_Diu

1005

544

0.41

0.41

1327

ACEI_Diu

1683

167

1.02

1.02

164

   ACEI_Diu_Sta

1259

254

0.49

0.08

3175

ACEI_Diu_Sta

1827

144

1.28

0.26

554

High risk

     

Very high risk

     

   No treatment

1695

 

0.00

  

No treatment

2028

 

0.00

  

   ACEI_CCB_Diu

2240

545

1.56

1.56

349

ACEI_CCB_Diu_ASA

3244

1216

2.44

2.44

498

   ACEI_CCB_Diu_Sta

2404

164

1.83

0.27

607

ACEI_CCB_Diu_Sta_ASA

3433

189

2.73

0.29

652

CVD risk with diabetes

Strategy

Cost

IC

Eff

IE

ICER

Strategy

Cost

IC

Eff

IE

ICER

Low risk

     

Moderate risk

     

   No treatment

964

 

0.00

  

No treatment

1805

 

0.00

  

   Sulf_ACEI_CCB

1481

517

0.85

0.85

608

Sulf_ACEI_CCB

1966

161

1.40

1.40

115

   Big_Sulf_ACEI_CCB

1778

297

1.16

0.31

958

Big_Sulf_ACEI_CCB

2122

156

2.01

0.61

256

   Big_Sulf_ACEI_CCB_Sta

2026

248

1.26

0.10

2480

Big_Sulf_ACEI_CCB_Sta

2311

189

2.21

0.20

945

High risk

     

Very high risk

     

   No treatment

1909

 

0.00

  

No treatment

2514

 

0.00

  

   Big_Sulf_ACEI_CCB

2576

667

2.16

2.16

309

Big_Sulf_ACEI_CCB_ASA

3696

1182

3.38

3.38

350

   Big_Sulf_ACEI_CCB_Sta

2768

192

2.37

0.21

914

Big_Sulf_ACEI_CCB_Sta_ASA

3893

197

3.66

0.28

704

   Big_Sulf_ACEI_ARB_CCB_Sta

3798

1030

2.47

0.10

10300

Big_Sulf_ACEI_ARB_CCB_Sta_ASA

4883

990

3.79

0.13

7615

  1. IC Incremental cost, Eff Effectiveness, IE Incremental effectiveness, ICER Incremental cost-effectiveness ratio